Pregled bibliografske jedinice broj: 307751
Evaluation of HI-6 oxime: potential use in protection of human acetylcholinesterase inhibited by antineoplastic drug irinotecan and its possible cyto / genotoxicity in vitro
Evaluation of HI-6 oxime: potential use in protection of human acetylcholinesterase inhibited by antineoplastic drug irinotecan and its possible cyto / genotoxicity in vitro // Acta biochimica Polonica, 54 (2007), 3; 583-593 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 307751 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Evaluation of HI-6 oxime: potential use in protection of human acetylcholinesterase inhibited by antineoplastic drug irinotecan and its possible cyto / genotoxicity in vitro
Autori
Radić, Božica ; Lucić Vrdoljak, Ana ; Želježić, Davor ; Fuchs, Nino ; Berend, Suzana ; Kopjar, Nevenka
Izvornik
Acta biochimica Polonica (0001-527X) 54
(2007), 3;
583-593
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Hi-6; Acetylcholinesterase; Irinotecan; Protection; Reactivation; Comet assay; Chromosome aberrations; apoptosis; Micronuclei
Sažetak
The function of acetylcholinesterase (AChE) is the rapid hydrolysis of the neurotransmitter acetylcholine (ACh), which is involved in the numerous cholinergic pathways in both, the central and the peripheral nervous system. Therefore, AChE measurement is of high value for therapy management, especially during the course of the intoxication with different chemicals or drugs that inhibits activity of enzyme. Different substances, pyridinium or bispyridinium aldoximes (oximes) among them, are able for the recovery of inhibited enzyme. Since their adverse effects are not well elucidated, in this study the efficiency of HI-6 oxime in protection and/or reactivation of human erythrocyte (AChE) inhibited by antineoplastic drug irinotecan as well as its cyto / genotoxicity in vitro were investigated. HI-6 increases the activity of AChE to 30% ; residual activity after irinotecan inhibition was 7%. Also, it reactivated the enzyme previously inhibited by irinotecan (4.6 mg/ml) by 50% when applied in a concentration of ¼ of the IC50 value. Tested concentrations of HI-6 exhibited acceptable genotoxicity on white blood cells, as estimated by the alkaline comet assay, DNA diffusion assay and cytogenetic endpoints (structural chromosome aberrations and cytokinesis-block micrunucleus assay). The results obtained sustain the further investigation of HI-6 in vivo, as well as its development for possible application in chemotherapy.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
022-0222148-2137 - Genotoksičnost kemijskih i fizikalnih agensa prirodnog i antropogenog podrijetla (Kašuba, Vilena, MZOS ) ( CroRIS)
022-0222148-2139 - Terapijski učinak novosintetiziranih spojeva pri otrovanju organofosfatima (Lucić Vrdoljak, Ana, MZOS ) ( CroRIS)
Ustanove:
Institut za medicinska istraživanja i medicinu rada, Zagreb
Profili:
Suzana Žunec
(autor)
Davor Želježić
(autor)
Ana Lucić Vrdoljak
(autor)
Božica Radić
(autor)
Nevenka Kopjar
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE